Stock Earnings

Question 1

What are Rosetta Genomics Ltd's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Rosetta Genomics Ltd has a total asset of $11, Net loss of $-16

Question 2

What are the key financial ratios for ROSGQ?

Accepted Answer

Rosetta Genomics Ltd's Current ratio is 1.57, has a Net margin is -177.77, sales per share of $5.16.

Question 3

How is Rosetta Genomics Ltd's revenue broken down by segment or geography?

Accepted Answer

Currently Rosetta Genomics Ltd data is not available.

Question 4

Is Rosetta Genomics Ltd profitable?

Accepted Answer

no, according to the latest financial statements, Rosetta Genomics Ltd has a net loss of $-16

Question 5

Does Rosetta Genomics Ltd have any liabilities?

Accepted Answer

yes, Rosetta Genomics Ltd has liability of 7

Question 6

How many outstanding shares for Rosetta Genomics Ltd?

Accepted Answer

Rosetta Genomics Ltd has a total outstanding shares of 1.84

Breakdown	TTM	12/31/2016	12/31/2015	12/31/2014	12/31/2013	12/31/2012
Revenue	5	9	8	1	0	0
Revenue Growth (YoY)	-38%	13%	700%	--	--	--
Cost of Revenue	4	7	6	1	0	0
Gross Profit	0	1	1	0	0	0
Selling, General & Admin	10	14	14	12	11	6
Research & Development	2	3	2	1	1	1
Operating Expenses	13	17	17	14	13	8
Other Non Operating Income (Expenses)	--	0	0	--	--	--
Pretax Income	-11	-16	-17	-14	-13	-10
Income Tax Expense	0	0	0	0	0	0
Net Income	-13	-16	-17	-14	-12	-10
Net Income Growth	-28%	-6%	21%	17%	20%	25%
Shares Outstanding (Diluted)	2.54	1.74	1.25	0.93	0.79	0.63
Shares Change (YoY)	46%	39%	34%	17%	26%	0%
EPS (Diluted)	-5.25	-9.31	-13.79	-15.5	-16.13	-16.48
EPS Growth	-50%	-32%	-11%	-4%	-2%	18%
Free Cash Flow	-11	-10	-17	-13	-11	-8
Free Cash Flow Per Share	-4.32	-5.73	-13.51	-13.87	-13.75	-12.61
Gross Margin	0%	11.11%	12.5%	0%	0%	0%
Operating Margin	-240%	-166.66%	-187.5%	-1,400%	0%	0%
Profit Margin	-260%	-177.77%	-212.5%	-1,400%	0%	0%
Free Cash Flow Margin	-220%	-111.11%	-212.5%	-1,300%	0%	0%
EBITDA	-12	-15	-15	-14	-13	-8
EBITDA Margin	-240%	-166.66%	-187.5%	-1,400%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-12	-15	-15	-14	-13	-8
EBIT Margin	-240%	-166.66%	-187.5%	-1,400%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Rosetta Genomics Ltd (ROSGQ) Price